Back to search

Article

Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis

2025-05-08

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Nirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During the 2024 RSV season in Western Australia, 23,525 doses were administered to infants entering their first season, and 1,233 doses to at-risk children. In this context, the selection and spread of escape variants is a potential con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d783c5a-f84f-598f-81dc-51182a4e6371
DOI
10.1101/2025.05.07.25326957
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Respiratory Syncytial virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab ProphylaxisDOI 10.1101/2025.05.07.25326957
Genomic Surveillance and Antigenic Characterization of Respiratory Syncytial Virus (RSV) in Spain During the 2023-2024 Season of Nirsevimab Administration.Semantic proximity
Real-world emergence of nirsevimab resistance in breakthrough infections with respiratory syncytial virus-B: a multicentre observational study in France.Semantic proximity
Wastewater-based sequencing of Respiratory Syncytial Virus enables tracking of lineages and identifying mutations at antigenic sitesSemantic proximity
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus.Semantic proximity
Wastewater-based sequencing of respiratory syncytial virus to investigate lineage dynamics and antigenic site mutations: a retrospective genomic epidemiology study.Semantic proximity
Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trialsSemantic proximity
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world studySemantic proximity
Complex intra-host SARS-CoV-2 evolution following monoclonal antibody pre-exposure prophylaxisSemantic proximity
Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.Semantic proximity
Tracking Respiratory Syncytial Virus dynamics in wastewater during the 2024-2025 season in SwitzerlandSemantic proximity
Subtype-specific differences in susceptibility to monoclonal antibodies and vaccines among contemporary RSV-A and RSV-B isolatesSemantic proximity
The molecular epidemiology of respiratory syncytial virus in Ontario, Canada from 2022–2024 using a custom whole genome sequencing assay and analytics packageSemantic proximity
Select a neighboring publication to make it the new centre.